Wells Fargo & Company Annexon, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Annexon, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 150,616 shares of ANNX stock, worth $876,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,616
Previous 28,905
421.07%
Holding current value
$876,585
Previous $207,000
256.52%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$49.2 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$43.1 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$40.7 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$38.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$37.4 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $277M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...